Alexandra Femc
Nurse Practitioner · Norwich, CTNPI 1255005120
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,437 of the $6,135 with a category attached, or 88.6%. It is spread thinly across 51 manufacturers, the largest accounting for just 9.5% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $21.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$580
- Bayer$507
- Johnson & Johnson$502
- AstraZeneca$482
- Rigel Pharmaceuticals, Inc.$438
- Takeda Pharmaceuticals U.S.A., Inc.$326
- plus $3K from 45 others
What the payments were for
- Food & beverage$5,43789%
- Education$69811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,135 in reported general payments places this provider in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbrancePalbociclib | 15 | $240,407 |
| ErleadaApalutamide | 11 | $167,095 |
| NubeqaDarolutamide | 12 | $158,736 |
| NeulastaPegfilgrastim | 19 | $133,295 |
| XareltoRivaroxaban | 20 | $22,084 |
| EliquisApixaban | 11 | $9,181 |
| Exemestane | 12 | $2,865 |
| Oxycodone Hcl | 41 | $538 |
| Letrozole | 11 | $429 |
| Anastrozole | 15 | $338 |
| Mirtazapine | 15 | $237 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 15 | $98 |
| Prednisone | 13 | $68 |
| Gabapentin | 12 | $63 |
| Alprazolam | 15 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerIbrance, Eliquis | $212 | $249,58826 claims |
| Johnson & JohnsonErleada, Xarelto | $502 | $189,17931 claims |
| BayerNubeqa | $507 | $158,73612 claims |
| AmgenNeulasta | $67 | $133,29519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.
Other nurse practitioner in Norwich
- Paul FidrychNorwich$23K
- Priscilla QuilterNorwich$21K
- Kristen Church-ReedNorwich$4K
- Lindita VincaCheshire$427K
- Catherine MilnePlymouth$361K
- Michele NovellaDanbury$331K
- Tiffany RydzNewtown$49K
- Kimberly BoldonMiddletown$19K
- Emma RobinsonStamford$17K
- Janice TavaresBridgeport$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.